Lumos Pharma Inc. (LUMO)
NASDAQ: LUMO
· Real-Time Price · USD
4.34
0.00 (0.00%)
At close: Dec 11, 2024, 10:00 PM
Lumos Pharma Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.08 | -0.61 | -0.55 | -0.68 | -0.79 | -0.75 | -1.02 | -0.97 | -2.56 | -2.07 | -2.55 | -2.56 | -2.64 | -2.52 | -2.82 |
PEG Ratio | 0.33 | 0.02 | -0.05 | -0.05 | 0.17 | -0.02 | 0.08 | -0.12 | 0.34 | -1.91 | -0.07 | 0.10 | 0.29 | 0.52 | -0.01 |
PS Ratio | 44.39 | 37.57 | 139.50 | 31.19 | 3.76K | 51.13 | 39.47 | 58.30 | 149.36 | 159.77 | 707.79 | 262.68 | n/a | 8.73K | n/a |
PB Ratio | 6.56 | 1.78 | 1.32 | 0.94 | 0.74 | 0.62 | 0.52 | 0.50 | 1.10 | 0.86 | 0.96 | 0.65 | 0.84 | 0.86 | 0.89 |
P/FCF Ratio | -6.44 | -2.87 | -1.79 | -1.25 | -18.28 | -2.54 | -2.34 | -5.1 | -13.45 | -8.89 | -9.78 | -9.89 | -11.23 | -13.69 | -9.35 |
P/OCF Ratio | -6.44 | -2.87 | -1.79 | -3.48 | -3.37 | -4.03 | -2.97 | -5.12 | -13.45 | -8.89 | -9.78 | -9.92 | -11.24 | -13.71 | -9.35 |
OCF/S Ratio | -6.9 | -13.07 | -78.15 | -8.95 | -1.12K | -12.69 | -13.31 | -11.38 | -11.1 | -17.98 | -72.37 | -26.49 | n/a | -636.9 | n/a |
Debt / Equity Ratio | 0.04 | 0.63 | 0.37 | 0.24 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
Quick Ratio | 2.66 | 4.23 | 6.24 | 5.69 | 7.76 | 8.55 | 12.61 | 10.73 | 14.38 | 17.59 | 17.67 | 19.46 | 17.47 | 16.74 | 24.00 |
Current Ratio | 2.66 | 4.23 | 6.24 | 5.69 | 7.76 | 8.55 | 12.61 | 10.73 | 14.38 | 17.59 | 17.67 | 19.43 | 17.47 | 16.74 | 24.00 |
Asset Turnover | 0.04 | 0.02 | 0.01 | 0.02 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | n/a | 0.00 | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -107.08 | n/a | n/a | n/a | n/a | -232.89 |
Return on Equity | -1.52 | -0.73 | -0.6 | -0.35 | -0.23 | -0.2 | -0.13 | -0.13 | -0.11 | -0.1 | -0.09 | -0.06 | -0.08 | -0.09 | -0.08 |
Return on Assets | -0.43 | -0.35 | -0.37 | -0.23 | -0.17 | -0.16 | -0.1 | -0.11 | -0.09 | -0.09 | -0.08 | -0.06 | -0.07 | -0.08 | -0.07 |
Return on Invested Capital | -0.69 | -0.46 | -0.45 | -0.29 | -0.21 | -0.19 | -0.12 | -0.12 | -0.1 | -0.1 | -0.09 | -0.06 | -0.07 | -0.08 | -0.08 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 1.00 | 1.00 | 0.99 | 0.98 | -0.14 | 0.98 | 0.99 | 0.93 | 1.00 | 1.00 | 0.89 | 1.00 | n/a | 1.00 | n/a |
Net Profit Margin | -10.29 | -15.47 | -63.28 | -11.45 | -1.19K | -16.95 | -9.63 | -14.98 | -14.59 | -19.27 | -69.45 | -25.64 | n/a | -867 | n/a |
Pretax Profit Margin | -10.29 | -15.47 | -63.28 | -11.45 | -1.19K | -17 | -10.63 | -16.13 | -14.59 | -19.46 | -69.55 | -28.53 | n/a | -867 | n/a |
Operating Profit Margin | -10.52 | -16.03 | -65.83 | -12.11 | -1.28K | -18.3 | -11.63 | -17.26 | -15.19 | -19.66 | -69.65 | -29.86 | n/a | -866.4 | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -10.52 | -16.03 | -65.82 | -12.09 | -1.27K | -18.28 | -11.62 | -17.19 | -15.18 | -19.46 | -69.54 | -30.74 | n/a | -865.1 | n/a |